Protara Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $63.4M | $40.0M |
| FY2016 | — | $38.4M | $36.4M |
| FY2017 | — | $34.7M | $21.2M |
| FY2018 | — | $4.8M | $19.4M |
| FY2019 | — | $-2.1M | $564.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $63.4M | $40.0M |
| FY2016 | — | $38.4M | $36.4M |
| FY2017 | — | $34.7M | $21.2M |
| FY2018 | — | $4.8M | $19.4M |
| FY2019 | — | $-2.1M | $564.0K |